MELVILLE, N.Y., March 22, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the Company) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the United States Patent Office and several International agencies have issued notices of allowance for three separate patent applications related to the Companys metabolic ThermoStem Program
Purpose:To perform a network meta-analysis to evaluate clinical efficacy and treatment related adverse events (AEs) of intra-articular hyaluronic acid (HA), leukocyte-poor platelet-rich plasma (LP-PRP), leukocyte-rich platelet-rich plasma (LR-PRP), bone marrow mesenchymal stem cells (BM-MSCs), adipose mesenchymal stem cells (AD-MSCs) and saline (placebo) during 6 and 12 months of follow-up. Methods:Six databases were searched for randomized controlled trials. Outcome assessment included the visual analog scale (VAS) score, Western Ontario and McMaster Universities Osteoarthritis (WOMAC) pain subscore, WOMAC score, International Knee Documentation Committee (IKDC) subjective score, and treatment-related AEs
This article was originally published here Stem Cell Res Ther.
MELVILLE, N.Y., March 18, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc.
This article was originally published here Biochimie. 2021 Mar 9:S0300-9084(21)00073-0. doi: 10.1016/j.biochi.2021.03.003
This article was originally published here Clin Immunol. 2021 Mar 5:108712
This article was originally published here Methods Mol Biol. 2021;2269:49-61. doi: 10.1007/978-1-0716-1225-5_4.
Bone and cartilage formation in the embryo and repair and turnover in the adult involve the progeny of a small number of cells called mesenchymal stem cells. These cells divide, and their progeny become committed to a specific and distinctive phenotypic pathway, a lineage with discrete steps and, finally, end-stage cells involved with fabrication of a unique tissue type, e.g., cartilage or bone. Local cuing (extrinsic factors) and the genomic potential (intrinsic factors) interact at each lineage step to control the rate and characteristic phenotype of the cells in the emerging tissue
This article was originally published here Front Oncol. 2021 Feb 18;10:584683. doi: 10.3389/fonc.2020.584683
(March 2021) Polaris Market Research recently released a Mesenchymal Stem CellsMarket report. The report provides the overall scope of the market, including future supply and demand, emerging market trends, high growth opportunities and in-depth analysis of the markets future prospects. The report discusses competitive data analysis of emerging markets and leading market participants
Recent Comments